两家公司宣布,合并后的公司更名为“tras Pharma, Inc.”,由新任首席执行官Werner Cautreels领导,将于周三在纳斯达克上市交易,股票代码为“TRAW”。
TRAW即将到来的里程碑包括在2024年下半年开始...查看全文
$ONCONOVA THERAPEUTICS INC(ONTX)$ 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Filed: 2017-03-29 AccNo: 0001047469-17-002146 Size: 8 MB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2017-03-27 AccNo: 0001104659-17-019283 Size: 140 KBItem 2.02: Results of Operations and Financial ConditionItem 9.01: Financial Statements and Exhibits 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 美东时间 2017-03-27 盘前 披露财报,预期EPS n/a 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-14 AccNo: 0001193125-17-043588 Size: 106 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals Filed: 2017-02-06 AccNo: 0000950103-17-001127 Size: 99 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ S-8 - Securities to be offered to employees in employee benefit plans Filed: 2017-01-17 AccNo: 0001104659-17-002563 Size: 118 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2016-12-15 AccNo: 0001104659-16-162347 Size: 21 KBItem 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 424B5 - Prospectus [Rule 424(b)(5)] Filed: 2016-12-05 AccNo: 0001104659-16-160514 Size: 367 KB 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2016-12-05 AccNo: 0001104659-16-160513 Size: 350 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接
$ONCONOVA THERAPEUTICS INC(ONTX)$ 8-K - Current report Filed: 2016-12-05 AccNo: 0001104659-16-160512 Size: 388 KBItem 8.01: Other EventsItem 9.01: Financial Statements and Exhibits 网页链接